Patent · US Active

Antibodies and conjugates thereof

US11066465B2 · kind B2 · utility

6Cited by
250References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2016
Grant dateJul 20, 2021
Priority date
Expiry dateDec 29, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are anti-VEGF-A antibodies and antibody conjugates thereof. Some embodiments of the antibodies can be conjugated to a moiety, such as a HEMA-PC polymer. Some embodiments of the antibody conjugates can retain or enhance antibody activity. The antibody and conjugate thereof can be particularly useful for treating diabetic retinopathy. Further provided are methods for conjugation of a polymer to a protein such as an antibody, such as IgG1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.